Purple Biotech (PPBT) Capital Expenditures (2017 - 2023)
Purple Biotech's (PPBT) quarterly Capital Expenditures came in at $6000.0 in Q4 2023, down 88.46% year-on-year from $52000.0 in Q4 2022, and up 500.0% on a QoQ basis from $1000.0 in Q3 2023.
Purple Biotech (PPBT) Capital Expenditures (2017 - 2023) Analysis & Trends
Purple Biotech (PPBT) has 7 years of Capital Expenditures data on file, last reported at $6000.0 in Q4 2023.
- On a quarterly basis, Capital Expenditures fell 88.46% year-over-year to $6000.0 in Q4 2023; TTM through Dec 2023 was $3000.0, a 88.46% decrease from a year earlier, with the FY2025 full-year figure at $3000.0, changed N/A from the prior year.
- Capital Expenditures for Q4 2023 stood at $6000.0, up from $1000.0 in the prior quarter.
- Over the last five years, Capital Expenditures for PPBT reached as high as $52000.0 in Q4 2022 and fell as low as -$156000.0 in Q4 2020.
- Historically, Capital Expenditures has averaged -$17928.6 across 5 years, with a median of -$6000.0 in 2021.
- Across the five-year window, Capital Expenditures sank 5100.0% in 2020 and soared 966.67% in 2022, its largest moves.
- Year by year, Capital Expenditures stood at -$3000.0 in 2019, then sank by 5100.0% to -$156000.0 in 2020, then jumped by 96.15% to -$6000.0 in 2021, then surged by 966.67% to $52000.0 in 2022, then sank by 88.46% to $6000.0 in 2023.
- Per Business Quant data, the three most recent Capital Expenditures figures were $6000.0 in Q4 2023, $1000.0 in Q3 2023, and -$1000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Purple Biotech | 1.33 Bn | 1.33 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 6,000.00 |
| Dec 31, 2023 | 6,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | -1,000.00 |
| Jun 30, 2023 | -1,000.00 |
| Mar 31, 2023 | -3,000.00 |
| Mar 31, 2023 | -3,000.00 |
| Dec 31, 2022 | 52,000.00 |
| Dec 31, 2022 | 52,000.00 |
| Sep 30, 2022 | -6,000.00 |
| Sep 30, 2022 | -6,000.00 |
| Jun 30, 2022 | -6,000.00 |
| Jun 30, 2022 | -6,000.00 |
| Mar 31, 2022 | -14,000.00 |
| Mar 31, 2022 | -14,000.00 |
| Dec 31, 2021 | -6,000.00 |
| Dec 31, 2021 | -6,000.00 |
| Sep 30, 2021 | -6,000.00 |
| Sep 30, 2021 | -6,000.00 |